2015 American Transplant Congress Archives - Page 3 of 170

2:27pm-2:39pm: Early Conversion to Everolimus in De Novo Kidney Transplant Recipients: 12-Month Results from the ELEVATE Study

J. de Fijter, H. Holdaas, A. Speziale, G. Junge, Z. Wang, J. Cruzado, M. van der Giet.

Concurrent Session: Kidney: Immunosupression Minimization • Room 113-BC

2:27pm-2:39pm: Kidney Double Negative TCR αβ + Cells: Newly Described Intra-Renal Kidney Lymphocytes That Respond to Ischemia Reperfusion in Mice

M. Martina,¹ S. Bandapalle,² S. Noel,² A. Saxena,¹ A. Hamad,¹ H. Rabb.²

Concurrent Session: Ischemia Reperfusion Injury: Basic Mechanisms • Room 119-A

2:27pm-2:39pm: Natural History of Anti- Human Leukocyte Antigen Antibodies After Hear Transplant

J. Kobashigawa, M. Kittleson, F. Liou, S. Siddiqui, R. Shiozaki, L. Piponniau, D. Geft, M. Hamilton, L. Czer, N. Reinsmoen, J. Patel.

Concurrent Session: Heart De-"Mystification": Rejection and Antibodies of All Types • Room 118-C

2:27pm-2:39pm: Non-Chimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic Biomarkers

J. Leventhal,¹ J. Mathew,¹ D. Salomon,² S. Kurian,² J. Friedewald,¹ L. Gallon,¹ I. Konieczna,¹ A. Tambur,¹ J. Levitsky,¹ Y. Kanwar,¹ C. Jie,¹ M. Abecassis,¹ J. Miller.¹

Concurrent Session: Tolerance: Clinical Studies • Room 122-AB

2:27pm-2:39pm: Pancreas Transplantation Immunosuppression Induction With Rabbit Antithymocyte Globulin +/- Rituximab and Early Steroid Withdrawal: Experience With >500 Recipients

J. Fridell,¹ R. Mangus,¹ J. Chen,² M. Mujtaba,³ T. Taber,³ M. Goble,¹ J. Powelson.¹

Concurrent Session: Optimizing Immunosuppression in Pancreas Transplantation • Room 119-B

2:27pm-2:39pm: Predicting and Preventing 30-Day Readmission Following Kidney Transplantation: A Single Center Study

R. Khaim,¹ V. Nair.^1,2

Concurrent Session: Kidney: Hospitalization/Readmission • Room 118-AB

2:27pm-2:39pm: Predicting Graft Loss in a Population of Kidney Transplant Patients Diagnosed With ABMR/TG

J. Reeve,¹ P. Halloran.¹

Concurrent Session: Immune Monitoring I • Room 120-ABC

2:27pm-2:39pm: Quantifying the Survival Benefit of HLA-Incompatible Kidney Transplantation: A Multi-Center Study

B. Orandi, X. Luo, A. Massie, J. Garonzik-Wang, B. Lonze, R. Ahmed, K. Van Arendonk, R. Montgomery, D. Segev.

Concurrent Session: Kidney: Desensitization • Terrace I-III

2:27pm-2:39pm: Rational Development of Alloantigen Specific Regulatory T Cell Therapy Requires Insight Into Longevity of Alloimmune Pathways

J. Ali, M. Negus, E. Bolton, J. Bradley, G. Pettigrew.

Concurrent Session: Transplant Tolerance: Animal Models I • Room 121-C

2:27pm-2:39pm: Safety and Efficacy of All Oral DAA Therapy for Genotype 1 HCV Post-Liver Transplant: Interval Results from the HCV-TARGET Multicenter Prospective Observational Study

J. O'Leary,¹ R. Brown,² K. Reddy,³ A. Kuo,⁴ G. Morelli,⁵ R. Stravitz,⁶ G. Everson,⁷ C. Durand,⁸ H. Vargas,⁹ P. Kwo,¹⁰ C. Frenette,¹¹ J. Peter,¹² M. Vainorius,¹² L. Akushevich,¹² D. Nelson,⁵ M. Fried,¹² N. Terrault.¹³

Concurrent Session: Liver Transplantation: Viral Hepatitis • Terrace IV